Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ruberg

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Vascular Medicine (London, England)|April 25, 2003
Prothrombotic determinants of coronary atherothrombosisFrederick L Ruberg, Joseph Loscalzo
Journal of Insurance Medicine (New York, N.Y.)|July 19, 2006
Newer cardiac imaging techniques: multidetector CT angiographyRavin Davidoff, Frederick L Ruberg
Current Opinion in Cardiology|February 19, 2021
Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapiesRabah Alreshq, Frederick L Ruberg
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 20, 2017
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African AmericansJoel N Buxbaum, Frederick L Ruberg
JAMA|March 5, 2024
Cardiac Amyloidosis Due to Transthyretin Protein: A ReviewFrederick L Ruberg, Mathew S Maurer
Trends in Cardiovascular Medicine|July 26, 2017
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatmentOmar K Siddiqi, Frederick L Ruberg
Circulation. Cardiovascular Imaging|June 15, 2021
Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to TreatmentRishi K Patel, Marianna Fontana, Frederick L Ruberg
Progress in Cardiovascular Diseases|May 25, 2002
Atherothrombosis: plaque instability and thrombogenesisFrederick L Ruberg, Jane A Leopold, Joseph Loscalzo
British Journal of Haematology|September 14, 2019
Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosisBrian Lilleness, Gheorghe Doros, Frederick L Ruberg, et al.
Current Heart Failure Reports|September 15, 2019
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac AmyloidosisDeepa M Gopal, Frederick L Ruberg, Omar K Siddiqi
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Vascular Medicine (London, England)|April 25, 2003
Prothrombotic determinants of coronary atherothrombosisFrederick L Ruberg, Joseph Loscalzo
Journal of Insurance Medicine (New York, N.Y.)|July 19, 2006
Newer cardiac imaging techniques: multidetector CT angiographyRavin Davidoff, Frederick L Ruberg
Current Opinion in Cardiology|February 19, 2021
Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapiesRabah Alreshq, Frederick L Ruberg
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 20, 2017
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African AmericansJoel N Buxbaum, Frederick L Ruberg
JAMA|March 5, 2024
Cardiac Amyloidosis Due to Transthyretin Protein: A ReviewFrederick L Ruberg, Mathew S Maurer
Trends in Cardiovascular Medicine|July 26, 2017
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatmentOmar K Siddiqi, Frederick L Ruberg
Circulation. Cardiovascular Imaging|June 15, 2021
Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to TreatmentRishi K Patel, Marianna Fontana, Frederick L Ruberg
Progress in Cardiovascular Diseases|May 25, 2002
Atherothrombosis: plaque instability and thrombogenesisFrederick L Ruberg, Jane A Leopold, Joseph Loscalzo
British Journal of Haematology|September 14, 2019
Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosisBrian Lilleness, Gheorghe Doros, Frederick L Ruberg, et al.
Current Heart Failure Reports|September 15, 2019
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac AmyloidosisDeepa M Gopal, Frederick L Ruberg, Omar K Siddiqi
Pageof 11